Clean Blood, Religion, and Moral Triage in Tuberculosis Vaccine Trials

被引:9
|
作者
Dixon, Justin [1 ,2 ]
Tameris, Michele [3 ]
机构
[1] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England
[2] Univ Durham, Dept Anthropol, Durham, England
[3] Univ Cape Town, Inst Infect Dis & Mol Med, Dept Pathol, Cape Town, South Africa
基金
英国经济与社会研究理事会;
关键词
South Africa; bioethics; clinical trials; morality; religion; tuberculosis; MEDICAL-RESEARCH; PERSPECTIVES; REFLECTIONS; EXPERIENCES; COMMUNITY; SCIENCE; ETHICS; NURSES; TRUTH;
D O I
10.1080/01459740.2018.1463528
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
During ethnographic research at a tuberculosis vaccine trial site in South Africa, trial participants often evoked the idiom of "clean blood." In this article, we illustrate how the trials enacted a form of moral triage in which "objective" bioscientific knowledge and moral subjectivity were coproduced. Participation created possibilities to demonstrate healthiness, respectability, and godliness in a context where positive self-imaginings were hard won, but could also lead to dejection and shame. We suggest that struggles to be recognized as virtuous are often overlooked in anthropological critiques of clinical trials and bioethics, but are important for understanding how trials meld with local moral worlds.
引用
收藏
页码:708 / 721
页数:14
相关论文
共 50 条
  • [21] MTBVAC: A Tuberculosis Vaccine Candidate Advancing Towards Clinical Efficacy Trials in TB Prevention
    Lacamara, Sergio
    Martin, Carlos
    ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59 (12): : 821 - 828
  • [22] Evaluation of vaccines to prevent childhood pneumonia: Lessons relevant to planning tuberculosis vaccine trials
    Mulholland, K
    CLINICAL INFECTIOUS DISEASES, 2000, 30 : S206 - S209
  • [23] Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design
    Ibango, Hannah B.
    Brookes, Roger H.
    Hill, Philip C.
    Owiafe, Patrick K.
    Fletcher, Helen A.
    Lienhardt, Christian
    Hill, Adrian V. S.
    Adegbola, Richard A.
    McShane, Helen
    LANCET INFECTIOUS DISEASES, 2006, 6 (08): : 522 - 528
  • [24] Considering human challenge trials for tuberculosis vaccine development (vol 40, pg 173, 2022)
    Kleinwaks, Gavriel
    Schmit, Virginia
    Morrison, Josh
    VACCINE, 2022, 40 (29) : 3984 - 3984
  • [25] Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?
    Nelson, Kristin N.
    Churchyard, Gavin
    Cobelens, Frank
    Hanekom, Willem A.
    Hill, Philip C.
    Lopman, Benjamin
    Mave, Vidya
    Rangaka, Molebogeng X.
    Vekemans, Johan
    White, Richard G.
    Wong, Emily B.
    Martinez, Leonardo
    Garcia-Basteiro, Alberto L.
    LANCET MICROBE, 2023, 4 (08): : E651 - E656
  • [26] Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials
    McShane, H
    Pathan, AA
    Sander, CR
    Goonetilleke, NP
    Fletcher, HA
    Hill, AVS
    TUBERCULOSIS, 2005, 85 (1-2) : 47 - 52
  • [27] The end of the road for blood RNA biomarkers as triage tests for symptomatic pulmonary tuberculosis among spontaneous sputum producers?
    Greenan-Barrett, James
    Gupta, Rishi K.
    Noursadeghi, Mahdad
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64 (02)
  • [28] Tuberculosis case finding for vaccine trials in young children in high-incidence settings: a randomised trial
    Moyo, S.
    Verver, S.
    Hawkridge, A.
    Geiter, L.
    Hatherill, M.
    Workman, L.
    Ontong, C.
    Msemburi, W.
    Tameris, M.
    Geldenhuys, H.
    Mulenga, H.
    Snowden, M. A.
    Hanekom, W. A.
    Hussey, G.
    Mahomed, H.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (02) : 185 - 191
  • [29] The prevalence of tuberculosis infection and disease among adolescents in Western Kenya: Preparation for future TB vaccine trials
    Nduba, V.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (08) : S24 - S24
  • [30] First-In-Human Trials of GamTBvac, a Recombinant Subunit Tuberculosis Vaccine Candidate: Safety and Immunogenicity Assessment
    Vasina, Daria V.
    Kleymenov, Denis A.
    Manuylov, Victor A.
    Mazunina, Elena P.
    Koptev, Egor Yu.
    Tukhovskaya, Elena A.
    Murashev, Arkady N.
    Gintsburg, Alexander L.
    Gushchin, Vladimir A.
    Tkachuk, Artem P.
    VACCINES, 2019, 7 (04)